Belite Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $31,668,000.

Profit Margin

Belite Bio, Inc (NASDAQ:BLTE): Profit margin
2020 0 -5.75M
2021 0 -9.79M
2022 0 -12.47M
2023 0 -31.63M

BLTE Income Statement (2020 – 2023)

2023 2022 2021 2020
Revenue
Revenue
0000
Cost of revenue
399K198K30K17K
Gross profit
-399K-198K-30K-17K
Operating exp.
Research and development
24.84M8.86M7.41M3.68M
Selling and marketing
0000
Total operating expenses
31.66M12.82M9.79M5.74M
Operating income
-31.66M-12.82M-9.79M-5.74M
Other income (expenses), net
45K173K131K-9K
Income before tax
-31.62M-12.64M-9.66M-5.75M
Income tax expense
9K-173K126K1K
Net income
-31.63M-12.47M-9.79M-5.75M
Earnings per share
Basic EPS
-1.19-0.62-0.41-0.24
Diluted EPS
-1.19-0.62-0.41-0.24
Data sourceData source